Openedges Technology, Inc. Logo

Openedges Technology, Inc.

Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.

394280 | KO

Overview

Corporate Details

ISIN(s):
KR7394280002
LEI:
Country:
South Korea
Address:
서울특별시 강남구 역삼로 114 현죽빌딩 13층, 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Openedges Technology, Inc. is a semiconductor intellectual property (IP) provider specializing in integrated solutions for artificial intelligence and high-performance computing. The company positions itself as a leading provider of a total memory subsystem and AI platform IP. Its product portfolio includes a range of solutions such as DDR memory controllers, DDR PHY, Network-on-Chip (NoC) interconnects, and Neural Processing Unit (NPU) IPs. These components are designed to enable efficient data processing for applications in AI, smart computing, and the Internet of Things (IoT). Founded in 2017, Openedges supplies essential modules for semiconductor companies developing advanced systems-on-chip (SoCs).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 29.3 KB
2025-09-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.7 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-07-31 00:00
Share Issue/Capital Change
전환주식의전환가액조정
Korean 12.2 KB
2025-07-18 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 200.6 KB
2025-07-18 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 133.0 KB
2025-07-18 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 157.9 KB
2025-07-14 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 10.4 KB
2025-07-01 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 27.2 KB
2025-06-27 00:00
Regulatory News Service
단일판매ㆍ공급계약체결(자율공시)
Korean 10.0 KB
2025-06-17 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 14.3 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 972.4 KB
2025-05-15 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 24.3 KB

Automate Your Workflow. Get a real-time feed of all Openedges Technology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Openedges Technology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Openedges Technology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel
NRGN
Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060

Talk to a Data Expert

Have a question? We'll get back to you promptly.